Costs, resource utilization, and treatment patterns for patients with metastatic melanoma in a commercially insured setting

To estimate real-world healthcare costs, resource utilization, and treatment patterns among metastatic melanoma (MM) patients who received a therapy recommended in current treatment guidelines during 2011 and 2012, following approval in the US of novel therapies (ipilimumab and vemurafenib). Adminis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current medical research and opinion Jg. 31; H. 8; S. 1561 - 1572
Hauptverfasser:	Toy, Edmond L., Vekeman, Francis, Lewis, Michael C., Oglesby, Alan K., Duh, Mei Sheng
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Informa Healthcare 03.08.2015
Schlagworte:	Adult Aged Antibodies, Monoclonal - therapeutic use Cohort Studies Female Health Care Costs Health Resources - utilization Healthcare costs Humans Ipilimumab Male Melanoma - secondary Melanoma - therapy Metastatic melanoma Middle Aged Resource utilization Retrospective Studies Treatment patterns Healthcare costs Metastatic melanoma Resource utilization Treatment patterns
ISSN:	0300-7995, 1473-4877
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!